Safeguarding our patients and our employees
At Celgene we have developed industry-leading programmes under which hundreds of thousands of patients worldwide have accessed the clinical benefits of our therapies.
- Educational materials for healthcare providers to ensure the correct use of our drugs
- Extremely careful monitoring of the use of our products to ensure patients can benefit from Celgene’s therapies
Our commitment to safety is grounded in our company’s commitment to improving the lives of patients worldwide.
Celgene’s commitment to Drug Safety Surveillance Activities
Every Celgene employee has a role in monitoring and reporting on the safe use of our products. The Celgene Global Drug Safety & Risk Management Department has more than 170 staff dedicated to safety monitoring via the Global Safety Network (GSN), an entity that spans every country in which Celgene is present including the UK.
The role of Celgene’s safety department
Celgene’s Global Drug Safety & Risk Management department ensures comprehensive safety monitoring by involving itself in every step of the clinical development process. Safety personnel are embedded within clinical development and project teams to ensure continuity of safety assessment at every stage from pre- to post-marketing.
How effective are Celgene’s safety systems?
Since the early days of Celgene, the company has been a leader in effective safety surveillance systems as a component of its broader risk management programmes. Safety is deeply engrained in our culture.
Our commitment to excellence is evident in results of our regulatory inspections. Despite an unprecedented number of inspections worldwide of Celgene’s drug safety systems, the outcomes have been consistently positive – this is a source of great pride for us. In addition to these outcomes, Celgene subjects its safety programmes to independent external benchmarking that compares our activities to more than 15 other leading biopharmaceutical companies. The results speak for themselves: Celgene consistently places among the highest performing companies.
Global Environmental Health and Safety (EHS) mission
Celgene is committed to global leadership in our environmental, health and safety programmes in order to effectively minimise occupational and environmental risks. We will strive to provide a safe, healthy and environmentally responsible work environment for all employees and visitors to our facilities.
- Integrate EHS objectives and targets into our business strategies and plans
- Comply with EHS laws, regulations, standards and ordinances in each of the countries in which we do business
- Educate employees with respect to EHS performance and provide training to assist employees in performing their responsibilities
- Strive for an injury-free and environmentally sustainable workplace by building on the belief that incidents, injuries and environmental releases are potentially preventable and by implementing appropriate risk-control measures
- Foster EHS ethics among management by setting management performance targets into our business strategies
- Act responsibly and communicate openly with our customers, neighbours, employees, government officials and other stakeholders relative to the safety profile of our products and operations
Act responsibly and communicate openly with our customers, neighbors, employees, government officials and other stakeholders relative to the safety profile of our products and operations.
EHS Areas of Responsibilities:
EHS assists Celgene in managing risk in the following areas:
- Occupational Health
- Product Safety
- Laboratory Services
Celgene is fortunate to have employees of the highest calibre, whose focus on the single mission of delivering innovative therapies to patients is what makes our company successful. We will continue to work towards ensuring the health and safety of all employees so we can maintain this extraordinary level of commitment and continue to attract the best employees at every level of our organisation.
Date of preparation: May 2015